Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. Clinics [Internet]. 2022 Nov. 29 [cited 2024 May 9];78:100150. Available from: https://www.journals.usp.br/clinics/article/view/213657